Composite complication (events = 242) | Wound complication (events = 49) | |||
---|---|---|---|---|
Patient characteristics | OR (95% CI) | P | OR (95% CI) | P |
Hyperglycemiab | 1.26 (0.65–2.43) | 0.49 | 1.06 (0.7–0.51) | 0.76 |
Age, yearsc | 1.35 (0.94–1.95) | 0.11 | 0.97 (0.7–1.35) | 0.88 |
BMI, kg/m2 | 1.05 (0.84–1.32) | 0.65 | 1.09 (0.86–1.39) | 0.48 |
Operative timec | 1.48 (1.19–1.85) | < 0.001 | 1.11 (0.88–1.39) | 0.38 |
Upper quartile EBL | 1.29 (1.13–1.47) | < 0.001 | 1.00 (0.97–1.03) | 0.89 |
ASA ≥ III | 1.11 (0.76-–.61) | 0.60 | 1.09 (0.79–1.51) | 0.63 |
Malignancy | 1.18 (0.65–2.16) | 0.58 | 1.09 (0.78–1.53) | 0.62 |
Cardiovascular disease | 1.00 (0.68–1.47) | 1.00 | 1.09 (0.79–1.51) | 0.610 |
Diabetes | 1.14 (0.68–1.91) | 0.61 | 1.09 (0.78–1.54) | 0.61 |
Surgical approach (laparotomy vs. MIS) | 2.13 (1.39–3.27) | < 0.001 | 1.28 (0.92–1.79) | 0.14 |
Division | 14 | |||
General Gyn/MIGS | Reference | Reference | 14 | |
Urogynecology | 1.12 (0.7–1.78) | 0.64 | 0.97 (0.69–1.36) | 0.85 |
Gynecology | 0.86 (0.45–1.62) | 0.63 | 1.09 (0.77–1.53) | 0.63 |